CLDN18 and gastric cancer: Taken together, these results suggest that GC cells with CLDN18-ARHGAP fusion promotes Treg cell survival and weakens anti-tumor cytotoxicity of NRTs through increased FFA production caused by the PI3K/AKT-mTOR-FAS signaling activation.